EMMPAGLIFLOZIN ORAL SOLID 10 MG BOX X BLISTER/STRIP

This tender concerns the procurement of Empagliflozin oral solid dosage form, specifically 10 mg strength, packaged in boxes of blisters or strips. The contracting entity is CENTRO MEDICO FAMILIAR INTEGRAL Y ESPECIALIDADES, DIALISIS LA MARISCAL. The specific process code for this tender is SIE-CMFIEDM-2025-040-748941. The requirement is for a quantity of 100,000 units, with an estimated value of USD 117,000.00. The procurement method specified is Electronic Reverse Auction (Subasta Inversa Electrónica). This modality typically involves suppliers competing by lowering their prices in response to bids. The tender is seeking to secure a supply of this specific pharmaceutical product, likely for use within the healthcare services provided by the CENTRO MEDICO FAMILIAR INTEGRAL Y ESPECIALIDADES. Interested suppliers should review the detailed specifications and bidding instructions associated with process code SIE-CMFIEDM-2025-040-748941 to understand the full scope of requirements, including quality standards, delivery timelines, and any other contractual obligations. The focus on Empagliflozin suggests a need for treatments related to conditions such as type 2 diabetes, cardiovascular disease, or chronic kidney disease, as this medication is commonly prescribed for these indications.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 117,000.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.